Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease.
Vaziri
Nosratola D
ND
Division of Nephrology and Hypertension, UCI Medical Center, 101 The City Drive, Bldg 53 Rm 125 Rt 81, Orange, CA 92868, USA. ndvaziri@uci.edu
Zhou
Xin J
XJ
D000740:Anemia / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D002318:Cardiovascular Diseases / Q000150:complications; D002908:Chronic Disease; D004921:Erythropoietin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006397:Hematinics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007674:Kidney Diseases / Q000150:complications*
D006397:Hematinics; D004921:Erythropoietin